274 related articles for article (PubMed ID: 15749258)
21. Selection bias in Teratology Information Service pregnancy outcome studies.
Johnson KA; Weber PA; Jones KL; Chambers CD
Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
[TBL] [Abstract][Full Text] [Related]
22. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole.
Källén B
Br J Obstet Gynaecol; 1998 Aug; 105(8):877-81. PubMed ID: 9746381
[TBL] [Abstract][Full Text] [Related]
23. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.
Magee LA; Inocencion G; Kamboj L; Rosetti F; Koren G
Dig Dis Sci; 1996 Jun; 41(6):1145-9. PubMed ID: 8654145
[TBL] [Abstract][Full Text] [Related]
24. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
25. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
27. [Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM)].
van Tonningen-van Driel MM; Garbis-Berkvens JM; Reuvers-Lodewijks WE
Ned Tijdschr Geneeskd; 1999 Jan; 143(1):27-31. PubMed ID: 10086095
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy outcome following exposure to permethrin and use of teratogen information.
Kennedy D; Hurst V; Konradsdottir E; Einarson A
Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
[TBL] [Abstract][Full Text] [Related]
30. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
31. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
[TBL] [Abstract][Full Text] [Related]
32. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
[TBL] [Abstract][Full Text] [Related]
33. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
[TBL] [Abstract][Full Text] [Related]
34. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
Iwagami M; Kumazawa R; Miyamoto Y; Ito Y; Ishimaru M; Morita K; Hamada S; Tamiya N; Yasunaga H
Drug Saf; 2021 Mar; 44(3):361-371. PubMed ID: 33247391
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcome of women exposed to azathioprine during pregnancy.
Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
[TBL] [Abstract][Full Text] [Related]
37. First-trimester exposure to alprazolam.
St Clair SM; Schirmer RG
Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
[TBL] [Abstract][Full Text] [Related]
38. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
Viinikainen K; Heinonen S; Eriksson K; Kälviäinen R
Epilepsia; 2006 Jan; 47(1):186-92. PubMed ID: 16417548
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
40. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
